Evaluation of the influence of polymorphic variants CYP1A12B, CYP1B12, CYP3A41B, GSTM10, and GSTT1*0 in prostate cancer (Q50559406)

15 March 2018

reason for preferred rank

title

Evaluation of the influence of polymorphic variants CYP1A1*2B, CYP1B1*2, CYP3A4*1B, GSTM1*0, and GSTT1*0 in prostate cancer (English)

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2010.01.009

23 July 2024

Evaluation of the influence of polymorphic variants CYP1A1 2B, CYP1B1 2, CYP3A4 1B, GSTM1 0, and GSTT1 0 in prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20884258

23 July 2024

Hellen Kuasne

1 reference

15 March 2018

Roberta Losi-Guembarovski

1 reference

15 March 2018

Kazuhiro Ito

1 reference

15 March 2018

Iara S. Rodrigues

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20884258

23 July 2024

Paulo E. Fuganti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20884258

23 July 2024

Emerson P. Gregório

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20884258

23 July 2024

Marina O. Kishima

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20884258

23 July 2024

Marco A. de Freitas Rodrigues

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20884258

23 July 2024

Ilce M. de Syllos Cólus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20884258

23 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20884258

23 July 2024

publication date

2 October 2010

1 reference

15 March 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S1078143910000372?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/J.UROLONC.2010.01.009

https://api.elsevier.com/content/article/PII:S1078143910000372?httpAccept=text/plain

23 July 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/J.UROLONC.2010.01.009

23 July 2024

1 reference

15 March 2018

volume

1 reference

15 March 2018

issue

1 reference

15 March 2018

page(s)

654-663

1 reference

15 March 2018

CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Prevalent mutations in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Genetic Polymorphisms in the 5′-Flanking Region Change Transcriptional Regulation of the Human Cytochrome P450IIE1 Gene1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Polymorphisms of the CYP1B1 gene have higher risk for prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Analysis of CYP1A1 exon 7 polymorphisms by PCR-SSCP in a Brazilian population and description of two novel gene variations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai Breast Cancer Study and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Ethnicity and glutathione S-transferase (GSTM1/GSTT1) polymorphisms in a Brazilian population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication no. 14. Considerations for population monitoring using cytogenetic techniques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

A simple salting out procedure for extracting DNA from human nucleated cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Epidemiology of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Mendelian inheritance of familial prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Descriptive epidemiology and risk factors for head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Variant in sex hormone-binding globulin gene and the risk of prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Expression of cytochrome P450 enzymes CYP1A1, CYP1B1, CYP2E1 and CYP4B1 in cultured transitional cells from specimens of the human urinary tract and from urinary sediments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

The CYP3A4 *1B polymorphism and prostate cancer susceptibility in a Portuguese population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Genetic basis of toxic reactions to drugs and chemicals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

GSTM1 polymorphism and oral squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Cytochrome P4501A1 and glutathione S-transferase M1 genotypes as risk factors for prostate cancer in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.01.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2010.01.009

Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2010.01.009

Prevalence of homozygosity for the deleted alleles of glutathione S-transferase mu (GSTM1) and theta (GSTT1) among distinct ethnic groups from Brazil: relevance to environmental carcinogenesis?

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2010.01.009

Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2010.01.009

23 July 2024

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018